Clinical Trial Update: A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating autologous neural stem cells for Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Autologous neural stem cells (autologous neural stem cells)

Snippet

Sponsor: Allife Medical Science and Technology Co., Ltd. | Conditions: Parkinson Disease | EARLY_Phase 1 | Status: UNKNOWN